Doctor profile · Federal record

Dr. Levent Akduman, MD

Ophthalmology Physician (CMS: Ophthalmology) · Ophthalmology Physician · Ophthalmology Physician · Ophthalmology Physician · Retina Specialist (Ophthalmology) Physician · St Louis, MO

  • NPI 1245344605
  • Accepts Medicare
  • MIPS 80.4 / 100 · 2023
  • 38 yrs in practice
  • Licensed in 4 states
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1755 S Grand
St Louis, MO 63104
(314) 256-3232
fax (314) 771-0596
Mailing address
3691 Rutger Ave, Provider Enrollment
St Louis, MO 63110

Credentials & registration

NPPES · NUCC
NPI registered
August 2006 — 20 yrs on file
Profile last updated
January 26, 2024
Year of graduation
1988 — 38 yrs since
Specialty taxonomy
207W00000X — NUCC code
State licenses (4)
Missouri #103873 · Florida #ME85158 · Illinois #036.094392 · Ohio #35.082957

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1245344605. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
31,870
Distinct HCPCS
10
Medicare allowed
$3,986,937
HCPCS Description Services Patients Avg allowed
J2777 Injection, faricimab-svoa, 0.1 mg 18,060 48 $36
67028 Injection of drug into eye 2,616 584 $127
J0178 Injection, aflibercept, 1 mg 2,448 262 $866
92134 Imaging of retina 1,996 656 $39
92250 Photography of the retina 1,465 1,058 $36
J9035 Injection, bevacizumab, 10 mg 1,337 304 $71
92014 Established patient complete exam of visual system 775 656 $122
Q5124 Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg 680 22 $215
J2778 Injection, ranibizumab, 0.1 mg 519 31 $232
99212 Established patient office or other outpatient visit, 10-19 minutes 431 373 $56

In context: peer comparison

Among 2 peers in St Louis Ophthalmology Physician, average services per provider: 795. This provider delivers 40× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$13,768
Transactions
47
Manufacturers
10
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 10 $8,467.04
Astellas Pharma US INC 9 $3,442.94
Alimera Sciences, INC. 10 $601.87
Genentech USA, INC. 5 $332.89
Alcon Vision LLC 3 $303.86
Regeneron Healthcare Solutions, INC. 4 $262.74
Apellis Pharmaceuticals, INC. 2 $139.05
Mallinckrodt Hospital Products INC. 1 $133.62
Sandoz INC. 2 $63.37
Bausch & Lomb Americas INC. 1 $20.14

By nature of payment

Compensation for Services Other Than Consulting, Including Serving As Faculty or As A Speaker at A Venue Other Than A Continuing Education Program
$8,000
Consulting Fee
$3,000
Food and Beverage
$2,768

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,222
Patients
544
Total drug cost
$84,552
Drug Type Claims Patients Total cost
Tobramycin-Dexamethasone (Tobramycin/Dexamethasone) Brand 242 201 $14,567
Latanoprost Generic 238 68 $6,721
Prednisolone Acetate Generic 161 64 $6,678
Dorzolamide Hcl Generic 133 51 $4,240
Brimonidine Tartrate Generic 123 38 $6,312
Timolol Maleate Generic 121 59 $1,553
Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) Brand 46 22 $1,575
Lumigan (Bimatoprost) Brand 36 0 $12,039
Brimonidine Tartrate-Timolol (Brimonidine Tartrate/Timolol) Brand 22 0 $7,466
Zylet (Tobramycin/Lotepred Etab) Brand 20 15 $6,446

Frequently asked questions

Auto-generated from federal data
What is Dr. Levent Akduman's medical specialty?
Dr. Levent Akduman practices Ophthalmology Physician in St Louis, MO.
Where does Dr. Levent Akduman practice?
Dr. Levent Akduman practices at 1755 S Grand, St Louis, MO 63104. Office phone: 3142563232.
What is Dr. Levent Akduman's NPI?
Dr. Levent Akduman's National Provider Identifier (NPI) is 1245344605, issued by NPPES.
Does Dr. Levent Akduman accept Medicare assignment?
Yes. Dr. Levent Akduman accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Levent Akduman commonly perform?
Top Medicare-reported procedures in 2023: Injection, faricimab-svoa, 0.1 mg (HCPCS J2777); Injection of drug into eye (HCPCS 67028); Injection, aflibercept, 1 mg (HCPCS J0178). Source: CMS Medicare Physician & Other Practitioners file.